CRBU Earnings

Quarterly EPS
$-0.39
Q4 2024
$-0.43
Q1 2025
$-0.58
Q2 2025
$-0.30
Q3 2025
$-0.28
Q4 2025
$-0.26
Q1 2026
$-0.24
Q2 2026
$-0.25
Q3 2026
Latest Revenue1.6M
Latest Net Income-26612000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.251.6M-26612000-26.9%+16.7%
Q2 2026-$0.241.5M-24282000-43.8%+58.6%
Q1 2026-$0.262.4M-25085000+1.9%+39.5%
Q4 2025-$0.283.9M-26488000+89.7%+28.2%
Q3 2025-$0.302.2M-27548000+8.6%+21.1%
Q2 2025-$0.582.7M-54098000-23.0%-38.1%
Q1 2025-$0.432.4M-39991000-3.1%+6.5%
Q4 2024-$0.392.1M-35490000-41.6%+0.0%
Q3 2024-$0.382.0M-34684000——
Q2 2024-$0.423.5M-37697000——
Q1 2024-$0.462.4M-41234000——
Q4 2023-$0.393.6M-34505000——
Caribou Biosciences (CRBU) — Earnings